GL1X · GenesisL1 explorer

Research workbench

Crystal structure of leubat (DELTA13 mutant) in complex with fluvoxamine

Analyse Crystal structure of leubat (DELTA13 mutant) in complex with fluvoxamine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MM9
Type
protein
Length
499 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transporter
UniProt
O67854
Ligands
FVX, NA
Pockets
5 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 77% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransporterprotein49977% helix, 1% strandO67854

Ligands and binding sites

  • FVX · Fluvoxamine · ligand · chains A
  • NA · Sodium ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17800.780.8267NA, FVX
2840.550.8618empty
3850.460.8015empty
4670.330.7513empty
5510.280.748empty

Compared structures

  • 4MM9 · Crystal structure of LeuBAT (delta13 mutant) in complex with fluvoxamine · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.